Clinical trial
Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or…
NCT00453999 · BioCryst Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00453999 |
|---|---|
| Title | Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza |
| Official title | Phase II, Multicenter, Randomized, Double-Mask, Double-Dummy Study Comparing Efficacy and Safety of Intravenous Peramivir Once Daily Versus Oral Oseltamivir Twice Daily in Adults With Acute Serious or Potentially Life-Threatening Influenza |
| Lead sponsor | BioCryst Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Drug |
| Interventions | Peramivir 200 mg, Peramivir 400 mg, Oseltamivir |
| Enrollment | 137 |
| Start date | Jul 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | Mar 29, 2007 |
| Last update posted | Feb 12, 2015 |
| Countries | Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: